Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H14NO4 |
Molecular Weight | 320.3188 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
C1OC2=C(O1)C=C3C(CC[N+]4=C3C=C5C=CC6=C(OCO6)C5=C4)=C2
InChI
InChIKey=XYHOBCMEDLZUMP-UHFFFAOYSA-N
InChI=1S/C19H14NO4/c1-2-16-19(24-10-21-16)14-8-20-4-3-12-6-17-18(23-9-22-17)7-13(12)15(20)5-11(1)14/h1-2,5-8H,3-4,9-10H2/q+1
Coptisine (COP), a protoberberine alkaloid, is widely found in Chinese medicinal plants (family Berberidaceae, Ranunculaceae and Papaveraceae). It is reported that COP has a wide range of pharmacological and biological activities, including antibacterial, hypoglycemic, anti-tumorigenic, and gastric-mucous membrane protection. Considerable attention has been focused on its activity against central nervous system disorders, such as improving the symptoms of Alzheimer’s disease and even preventing its onset, by exerting antidepressant effects as a potent type A monoamine oxidase inhibitor. Coptisine was found to be an efficient uncompetitive Indoleamine 2,3-dioxygenase inhibitor. Coptisine is a potent inhibitor of human organic cation transporters.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: map04210 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28165459 |
|||
Target ID: GO:0070371 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28165459 |
|||
Target ID: CHEMBL5685 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26134304 |
0.9 µM [IC50] | ||
Target ID: CHEMBL1743122 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26134304 |
2.3 µM [IC50] | ||
Target ID: CHEMBL2073673 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26134304 |
2.3 µM [IC50] | ||
Target ID: CHEMBL4685 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25079795 |
6.3 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. | 1991 Jan-Feb |
|
HIV-1 and HIV-2 reverse transcriptases: a comparative study of sensitivity to inhibition by selected natural products. | 1992 May 29 |
|
Interaction of benzo[c]phenanthridine and protoberberine alkaloids with animal and yeast cells. | 2001 |
|
Inhibition of type A monoamine oxidase by coptisine in mouse brain. | 2001 Dec 28 |
|
[The effects of kampo-formulation and the constituting crude drugs, prescribed for the treatment of peptic ulcer on H,K-ATPase activity]. | 2001 Feb |
|
In vitro cytotoxicity of the protoberberine-type alkaloids. | 2001 Jul |
|
Cytotoxicity evaluation of natural coptisine and synthesis of coptisine from berberine. | 2001 May-Jul |
|
Gastric-mucous membrane protection activity of coptisine derivatives. | 2001 Nov |
|
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by a Coptidis Rhizoma extract and protoberberine alkaloids. | 2002 Nov |
|
Positive cooperation of protoberberine type 2 alkaloids from Corydalis cava on the GABA(A) binding site. | 2003 Apr |
|
[Study on the solubility changes of Rhizoma Coptidis' main chemical constituents influenced by the proportion of Rhizoma Coptidis and Fructus Evodiae]. | 2003 Jul |
|
Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components. | 2004 Apr |
|
Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth. | 2004 Jan-Feb |
|
Study on noncovalent complexes of cytotoxic protoberberine alkaloids with double-stranded DNA by using electrospray ionization mass spectrometry. | 2004 Oct 4 |
|
[Quality assessment of Coptis chinensis in China]. | 2005 Apr |
|
Sensitivity improvement on detection of Coptidis alkaloids by sweeping in capillary electrophoresis. | 2005 Feb 7 |
|
[Studies on the alkaloids from herb of Corydalis adunca]. | 2005 Nov |
|
Double blockade of cell cycle progression by coptisine in vascular smooth muscle cells. | 2005 Oct 15 |
|
Simultaneous determination of four active alkaloids from a traditional Chinese medicine Corydalis saxicola Bunting. (Yanhuanglian) in plasma and urine samples by LC-MS-MS. | 2006 Feb 2 |
|
Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. | 2006 Jan 17 |
|
Bioavailabilty and pharmacokinetics of four active alkaloids of traditional Chinese medicine Yanhuanglian in rats following intravenous and oral administration. | 2006 Jun 16 |
|
Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine. | 2006 Mar 2 |
|
Selective inhibition of vascular smooth muscle cell proliferation by coptisine isolated from Coptis rhizoma, one of the crude drugs composing Kampo medicines Unsei-in. | 2006 May |
|
Simultaneous analysis of nine active components in Gegen Qinlian preparations by high-performance liquid chromatography with diode array detection. | 2006 Sep |
|
Simultaneous analysis of alkaloids from Zanthoxylum nitidum by high performance liquid chromatography-diode array detector-electrospray tandem mass spectrometry. | 2006 Sep 18 |
|
High performance liquid chromatography-mass spectrometry analysis of protoberberine alkaloids in medicine herbs. | 2007 Apr |
|
Analysis of Central European Corydalis species by nonaqueous capillary electrophoresis-electrospray ion trap mass spectrometry. | 2007 Aug 3 |
|
[Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers]. | 2007 Dec |
|
Simultaneous quantification of three alkaloids of Coptidis Rhizoma in rat urine by high-performance liquid chromatography: application to pharmacokinetic study. | 2007 Dec |
|
Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. | 2008 Apr 24 |
|
[Analysis of the main components of coptis-evodia herb couple by HPLC-DAD-MS]. | 2008 Mar |
|
Alkaloids from Corydalis saxicola and their anti-hepatitis B virus activity. | 2008 May |
|
Significant differences in alkaloid content of Coptis chinensis (Huanglian), from its related American species. | 2009 Aug 24 |
|
Bear bile: dilemma of traditional medicinal use and animal protection. | 2009 Jan 12 |
|
Hydroxyl radical scavenging activities of isoquinoline alkaloids isolated from Coptis chinensis. | 2009 Mar |
|
Inhibitory Effects of Coptidis rhizoma and Berberine on Cocaine-induced Sensitization. | 2009 Mar |
|
Purification of alkaloids from Corydalis yanhusuo W. T. Wang using preparative 2-D HPLC. | 2009 May |
|
Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisine. | 2010 |
|
[Simultaneous determination of the five alkaloids in Rhizoma Coptidis by nonaqueous capillary electrophoresis]. | 2010 Apr |
|
[Bio-activity evaluation of Qinlian Siwu decoction on inhibiting mice uterine contraction in vitro and its components analysis]. | 2010 Dec |
|
Quality assurance for Chinese herbal formulae: standardization of IBS-20, a 20-herb preparation. | 2010 Feb 22 |
|
[Pharmacodyamic material basis of rhizoma coptidis on insulin resistance]. | 2010 Jul |
|
[Simultaneous determination of six alkaloids in Coptis chinensis of different regions by RP-HPLC]. | 2010 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28165459
Mice: 50,100 or 150mg/kg body weight daily
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28165459
In HCT-116 cells, Coptisine exhibited cell cytotoxicity at a high rate (IC50 was 27.13 μg/mL vs 282.2 μg/mL in human colorectal epithelial cells FHC). Besides, Coptisine (2.5 μg/mL) decreased the survival rate of cells time-dependently .
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8323
Created by
admin on Fri Dec 15 19:49:54 GMT 2023 , Edited by admin on Fri Dec 15 19:49:54 GMT 2023
|
PRIMARY | |||
|
3486-66-6
Created by
admin on Fri Dec 15 19:49:54 GMT 2023 , Edited by admin on Fri Dec 15 19:49:54 GMT 2023
|
PRIMARY | |||
|
m3782
Created by
admin on Fri Dec 15 19:49:54 GMT 2023 , Edited by admin on Fri Dec 15 19:49:54 GMT 2023
|
PRIMARY | Merck Index | ||
|
COPTISINE
Created by
admin on Fri Dec 15 19:49:54 GMT 2023 , Edited by admin on Fri Dec 15 19:49:54 GMT 2023
|
PRIMARY | |||
|
72322
Created by
admin on Fri Dec 15 19:49:54 GMT 2023 , Edited by admin on Fri Dec 15 19:49:54 GMT 2023
|
PRIMARY | |||
|
DTXSID10188404
Created by
admin on Fri Dec 15 19:49:54 GMT 2023 , Edited by admin on Fri Dec 15 19:49:54 GMT 2023
|
PRIMARY | |||
|
0GCL71VN14
Created by
admin on Fri Dec 15 19:49:54 GMT 2023 , Edited by admin on Fri Dec 15 19:49:54 GMT 2023
|
PRIMARY | |||
|
C034384
Created by
admin on Fri Dec 15 19:49:54 GMT 2023 , Edited by admin on Fri Dec 15 19:49:54 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD